menu ☰
menu ˟

VIDEO: MONALEESA-7 shows ‘exciting’ results in premenopausal breast cancer

14 Jun 2019
CHICAGO — The MONALEESA-7 trial demonstrated that adding the CDK4/6 inhibitor ribociclib (Kisqali, Novartis) to endocrine therapy improved OS in patients with premenopausal or perimenopausal, metastatic, hormone receptor-positive breast cancer, Adi...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.